Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic

Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers limited broad uptake of buprenorphine among people who use drugs at the system, provider, and patient levels, including lack of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Linda, Weiss, Jeffrey, Ryan, Elizabeth Bogel, Waldman, Justine, Rubin, Stacey, Griffin, Judy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833481/
https://www.ncbi.nlm.nih.gov/pubmed/33771276
http://dx.doi.org/10.1016/j.jsat.2020.108272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833481/
https://www.ncbi.nlm.nih.gov/pubmed/33771276
http://dx.doi.org/10.1016/j.jsat.2020.108272

Ejemplares similares